Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lack of Effectiveness of Repurposed Drugs for COVID-19 Treatment
Miguel Ángel Martı́nez
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Drugs repurposed: An advanced step towards the treatment of breast cancer and associated challenges
Jonaid Ahmad Malik, Sakeel Ahmed, Bisma Jan, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 145, pp. 112375-112375
Open Access | Times Cited: 76
Therapeutics for COVID-19 and post COVID-19 complications: An update
Debdoot Basu, Vivek P. Chavda, Anita A. Mehta
Current Research in Pharmacology and Drug Discovery (2022) Vol. 3, pp. 100086-100086
Open Access | Times Cited: 69
Efficacy of repurposed antiviral drugs: Lessons from COVID-19
Miguel Ángel Martı́nez
Drug Discovery Today (2022) Vol. 27, Iss. 7, pp. 1954-1960
Open Access | Times Cited: 40
Controlling the COVID-19 pandemic through vaccination: a perspective from Indonesia
‎Rano K. Sinuraya, Auliya A. Suwantika, Maarten J. Postma
Expert Review of Vaccines (2025)
Open Access | Times Cited: 1
Efficacy and safety of hydroxychloroquine as pre-and post-exposure prophylaxis and treatment of COVID-19: A systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trials.
Paulo Ricardo Martins‐Filho, Lis Campos Ferreira, Luana Heimfarth, et al.
The Lancet Regional Health - Americas (2021) Vol. 2, pp. 100062-100062
Open Access | Times Cited: 46
Overcoming Therapy Resistance in Colon Cancer by Drug Repurposing
Talal El Zarif, Marcel Yibirin, Diana De Oliveira-Gomes, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2105-2105
Open Access | Times Cited: 29
Comparative docking studies of drugs and phytocompounds for emerging variants of SARS-CoV-2
Ananya Chugh, Ishita Sehgal, Nimisha Khurana, et al.
3 Biotech (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 17
Pulmonary surfactant as a versatile biomaterial to fight COVID-19
Lore Herman, Stefaan C. De Smedt, Koen Raemdonck
Journal of Controlled Release (2021) Vol. 342, pp. 170-188
Open Access | Times Cited: 28
Unlocking insights: Navigating COVID-19 challenges and Emulating future pandemic Resilience strategies with strengthening natural immunity
Sunil J. Wimalawansa
Heliyon (2024) Vol. 10, Iss. 15, pp. e34691-e34691
Open Access | Times Cited: 4
Comprehensive Fragment Screening of the SARS‐CoV‐2 Proteome Explores Novel Chemical Space for Drug Development
Hannes Berg, Maria A. Wirtz Martin, Nadide Altincekic, et al.
Angewandte Chemie International Edition (2022) Vol. 61, Iss. 46
Open Access | Times Cited: 17
Viruses as biomaterials
Tao Yang, Yingfan Chen, Yajing Xu, et al.
Materials Science and Engineering R Reports (2023) Vol. 153, pp. 100715-100715
Closed Access | Times Cited: 10
AI-Driven Discovery of SARS-CoV-2 Main Protease Fragment-like Inhibitors with Antiviral Activity In Vitro
Luiz Saramago, Marcos V. Santana, Bárbara Figueira Gomes, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 9, pp. 2866-2880
Closed Access | Times Cited: 10
Adapting an integrated acute respiratory infections sentinel surveillance to the COVID-19 pandemic requirements, Egypt, 2020–2022
Manal Fahim, Hanaa Abu Elsood, Basma AbdElGawad, et al.
Public Health in Practice (2023) Vol. 5, pp. 100358-100358
Open Access | Times Cited: 8
De Novo Design of Anti-COVID Drugs Using Machine Learning-Based Equivariant Diffusion Model Targeting the Spike Protein
Vidya Niranjan, Akshay Uttarkar, Ananya Ramakrishnan, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 5, pp. 4261-4284
Open Access | Times Cited: 8
Synthesis and In Vitro Study of Antiviral Activity of Glycyrrhizin Nicotinate Derivatives against HIV-1 Pseudoviruses and SARS-CoV-2 Viruses
В. В. Фоменко, Надежда Б. Рудометова, Оlga I. Yarovaya, et al.
Molecules (2022) Vol. 27, Iss. 1, pp. 295-295
Open Access | Times Cited: 14
Cyclophilin A‐mediated mitigation of coronavirus SARS‐CoV ‐2
Simranjeet Singh Sekhon, Woo‐Ri Shin, Sang Yong Kim, et al.
Bioengineering & Translational Medicine (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 14
Repurposing – second life for drugs
Porkodi Ayyar, Umamaheswari Subramanian
Pharmacia (2022) Vol. 69, Iss. 1, pp. 51-59
Open Access | Times Cited: 12
Corticosteroids: A boon or bane for COVID-19 patients?
Subhadeep Sen, Bhagat Singh, Goutam Biswas
Steroids (2022) Vol. 188, pp. 109102-109102
Open Access | Times Cited: 12
Engineered extracellular vesicles antagonize SARS-CoV-2 infection by inhibiting mTOR signaling
Ahmed Ibrahim, Alessandra Ciullo, Chih Chuan Lin Jen Hou Li, et al.
Biomaterials and Biosystems (2022) Vol. 6, pp. 100042-100042
Open Access | Times Cited: 11
Monitoring for SARS-CoV-2 drug resistance mutations in broad viral populations
Mayya Sedova, Lukasz Jaroszewski, Mallika Iyer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 11
Current Advances in Viral Nanoparticles for Biomedicine
Xianxun Sun, Tao Tian, Yindong Lian, et al.
ACS Nano (2024)
Closed Access | Times Cited: 2
In vitro testing and computational analysis of specific phytochemicals with antiviral activities considering their possible applications against COVID-19
Jovana Trifunović Ristovski, Mohammed Mahbubul Matin, Ren Kong, et al.
South African Journal of Botany (2022) Vol. 151, pp. 248-258
Open Access | Times Cited: 11
Targeting Specific Checkpoints in the Management of SARS-CoV-2 Induced Cytokine Storm
Abdullahi Rabiu Abubakar, Rahnuma Ahmad, Adekunle Babajide Rowaiye, et al.
Life (2022) Vol. 12, Iss. 4, pp. 478-478
Open Access | Times Cited: 11
Systematic Down-Selection of Repurposed Drug Candidates for COVID-19
Christopher A. MacRaild, Muzaffar-Ur-Rehman Mohammed, Faheem Faheem, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11851-11851
Open Access | Times Cited: 10
A fluorescence-based, gain-of-signal, live cell system to evaluate SARS-CoV-2 main protease inhibition
Rama Dey-Rao, George R. Smith, Uddhav Timilsina, et al.
Antiviral Research (2021) Vol. 195, pp. 105183-105183
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top